References
- Dargie HJ, Lynch PG, Krikler DM, Harris L, Krikler S. Nifedipine and propranolol: A beneficial drug interaction. Am J Med 1981; 71: 676–682
- Pfisterer M, Muller-Brand J, Burkart F. Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction. Am J Cardiol 1982; 49: 1259–1266
- Eggertsen R, Hansson L. Effects of treatment with nifedipine and metoprolol in essential hypertension. Eur J Clin Pharmacol 1982; 21: 389–390
- Anthony T, Jastremski M, Elliott W, Morris G, Prasad H. Charcoal hemoperfusion for the treatment of a combined diltiazem and metoprolol overdose. Ann Emerg Med 1986; 15: 1344–1348
- Haerer W, Stauch M. Intoxikation mit einem Nifedipine-Acebutolol-Kombinationsprdparat. Intensivmed Notf Med 1988; 25: 202–204
- Henry M, Kay MM, Viccellio P. Cardiogenic shock associated with calcium-channel and beta blockers: Reversal with intravenous calcium chloride. Am J Emerg Med 1985; 3: 334–336
- Dyrszka H, Wahn B. Klinisches Bild und Therapie einer Überdosis des Koronartheraputikums Nifedipine (Adalat). Inn Med 1977; 4: 31–34
- Bianchetti MG, Beretta-Piccoli C, Weidmann P, et al. Calcium and blood pressure regulation in normal and hypertensive subjects. Hypertension 1983; 5: 1157–65
- Brooks N, Cattell M, Pidgeon J, Balcon R. Unpredictable response to nifedipine in severe cardiac failure. Br Med J 1980; 281: 1324
- Whitebloom D, Fitzharris J. Nifedipine overdose. Clin Cardiol 1988; 11: 505–506
- Hamann SR, Kaltenborn KE, McAllister RG, Jr. Nifedipine-propranolol interaction: Dependence of cardiovascular effects on plasma drug concentrations. J Cardiovasc Pharmacol 1987; 10: 182–189
- Vick JA, Kandil A, Herman EH, Balazs T. Reversal of propranolol and verapamil toxicity by calcium. Vet Hum Toxicol 1983; 25: 8–10
- Möller B HJ. Massive intoxication with metoprolol. Br Med J 1976; 24: 222
- Etizolam. Martindale The Extra Pharmacopoeia, J EF Reynolds. The Pharmaceutical Press, London 1989; 737
- Zaritsky AL, Horowitz M, Chernow B. Glucagon antagonism of calcium channel blocker-induced myocardial dysfunction. Crit Care Med 1988; 16: 246–251
- Kosinski EJ, Malindzak GS. Glucagon and isoproterenol in reversing propranolol toxicity. Arch Intern Med 1973; 132: 840–843
- Schiffl H, Ziupa J, Schollmeyer P. Clinical features and management of nifedipine overdosage in a patient with renal insufficiency. J Toxicol Clin Toxicol 1984; 22: 387–395
- Shore ET, Cepin D, Davidson MJ. Metoprolol overdose. Ann Emerg Med 1981; 10: 524–527
- Raemsch KD, Sommer J. Pharmacokinetics and metabolism of nifedipine. Hypertension 1983; 5: II18–24
- Banzet O, Colin JN, Thibonnier M, et al. Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur J Clin Pharmacol 1983; 24: 145–150
- Weinstein RS. Recognition and management of poisoning with beta-adrenergic blocking agents. Ann Emerg Med 1984; 13: 1123–1131
- Levey GS, Epstein SE. Activation of adenyl cyclase by glucagon in cat and human heart. Circ Res 1969; 24: 151–156
- Collins S, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263: 9067–9070
- Ogawa T, Shingu K, Magaribuchi T, et al. Granulocyte beta-adrenoceptor density increased with methylprednisolone in patients receiving dopamine infusion. Masui 1990; 39: 1694–1700
- Taboulet P, Cariou A, Berdeaux A, Bismuth C. Pathophysiology and management of self-poisoning with beta-blockers. J Toxicol Clin Toxicol 1993; 31: 531–551